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Abstract
Background: The optimal control of blood volume without fluid overload is a main challenge in the daily care of
intensive care unit (ICU) patients. Accordingly this study focused on the identification of biomarkers to help
characterize fluid overload status.
Methods: Sixty-seven patients were studied from ICU admission to day 7 (D7). Blood and urine samples were taken
daily and sodium and water balance strictly calculated resulting in a total cumulative assessment of ΔNa+ and
ΔH2O. Furthermore, plasmatic biomarkers (cortisol, epinephrine, norepinephrine, renin, angiotensin II, aldosterone,
pro-endothelin, copeptine, atrial natriuretic peptide, erythropoietin, mid-regional pro-adrenomedullin (MR-proADM))
and Sequential Organ Failure Assessment (SOFA) scores were measured at D2, D5 and D7. Blood volumes were
measured with 51Cr fixed on red blood cells at D2 and D7.
Results: The ΔNa+ or ΔH2O were increased in all patients but never related to blood volumes at D2 nor D7. Total
blood volumes were at normal values with constantly low red blood cell volumes and normal or decreased
plasmatic volume. Weight, plasmatic proteins, and hemoglobin were weakly related to ΔNa+ or ΔH2O. Amongst all
tested biomarkers, only MR-proADM was related to sodium and fluid overload. This biomarker was also a predictor
of SOFA scores.
Conclusions: Plasmatic concentration in MR-proADM seems to be a good surrogate for evaluation of ΔNa+ or
ΔH2O and predicts sodium and extracellular fluid overload.
Trial registration: ClinicalTrials.gov: NCT01858675 in May 13, 2013.
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Background
The maintenance of optimal blood volume without the de-
velopment of a positive fluid balance is a major challenge in
the daily care of patients suffering from acute traumatic,
subarachnoid hemorrhage or infectious inflammatory
disorders [1–10]. Indeed, capillary leak significantly
contributes to the development of tissue edema and causes
persistent hypovolemia despite fluid resuscitation [11–13].
The consequence is two-fold, with (1) a large volume fluid
resuscitation and (2) an increase in tissue edema with
impairment of microcirculation architecture and oxygen
diffusion. This fluid overload caused by fluid resuscitation
and excess sodium can be the source of organ dysfunction,
including acute lung injury, abdominal compartment
syndrome and acute renal injury [2–5, 14, 15], thereby con-
tributing to higher mortality [7–9]. A 4-kg weight gain, cor-
responding to an accumulation of 4 L of water and 36 g of
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sodium chloride, is the limit beyond which morbidity and
mortality increase [3, 16–18].
The accurate monitoring of fluid balance is therefore
crucial in guiding fluid resuscitation. However, there is no
gold standard method for complete measurement and the
use of input/output charts in intensive care unit (ICU) pa-
tients is notorious for being incomplete and inaccurate.
Consequently, accurate and reproducible methods to im-
prove the monitoring of fluid balance are essential.
Several plasmatic biomarkers may contribute to arbi-
trating conflict between the control of optimal blood
volume and the development of fluid overload: these
include stress hormones, such as cortisol and catechol-
amines; hormones involved in volume regulation by
sodium chloride or water retention, such as the renin-
angiotensin II-aldosterone system [19]; vasopressin,
expressed by (CT)-pro-arginine vasopressin, known as
copeptin [20]; endothelin expressed by pro-endothelin
and atrial natriuretic peptide (ANP), measured by pro-
ANP; factors involved in the production of red blood
cells, such as erythropoietin (EPO) [21]; and factors that
repair the endothelium after injury, such as mid-regional
pro-adrenomedullin (MR-proADM) [22, 23].
The first aim of the Etude des marqueurs iNnovants
de la VOLémie (ENVOL study) was to identify a reliable
surrogate biomarker capable of predicting blood
volumes and/or cumulative sodium and water balance
(ΔNa+ and ΔH2O). We also tried to evaluate any rela-
tionship between extracellular volume and blood volume
measurements. For these purposes, we precisely charac-
terized changes in extracellular and blood volumes and
changes in several plasmatic biomarkers involved in vol-
ume regulation during the first 7 days of ICU stay.
Methods
This prospective, 7-day observational study was con-
ducted between March 2012 and September 2014 in the
38-bed Department of Anesthesiology and Intensive
Care at Bicêtre University Hospital, in Le Kremlin-
Bicêtre, France. The Institutional Review Board of the
hospital (Comité de protection des personnes Ile de France
VII) approved the study on December 2011 (reference 11-
045). Written informed consent was systematically ob-
tained from all participants included in the study or from
a relative, in accordance with French legal ethics.
We studied four groups of ICU patients, including
those with severe brain trauma (SBT), aneurysmal sub-
arachnoid hemorrhage (SAH), severe non-cerebral
trauma (NCT) or postoperative peritonitis with septic
shock (PPS). Patients were included if they required con-
tinuous mechanical ventilation on day 2. SBT was de-
fined as brain trauma with a Glasgow coma score of <9.
Patients with SAH were included in the presence of a
score ≥4 on the World Federation of Neurosurgical
Societies (WFNS) scale [24]. Patients with NCT were in-
cluded when the Injury Severity Score was ≥25. Patients
with PPS were included after abdominal surgery compli-
cated by manifestations of hemodynamic shock, includ-
ing hypotension and low cardiac output or lactate
concentration >4 mmol/L. Patients <18 years, pregnant
or presenting with New York Heart Association (NYHA)
graded ≥ II were excluded.
Data collection
During the ICU stay, general and demographic data
were collected, including age, sex, weight, height,
simplified index of illness severity after the first 48 h
(Simplified Index of Gravity (IGS) II) and admission
date. Sequential Organ Failure Assessment (SOFA)
scores were measured upon admission (day 0 (D0)),
and on days 2, 5 and 7 (D2, D5 and D7) [25]. Mean
arterial pressure, doses of norepinephrine and core
temperature were recorded daily. Blood laboratory tests in-
cluded measurements of hemoglobin, proteins, electrolytes,
creatinine and urinary concentrations of Na+, K+, Cl-, urea,
creatinine and osmolarity. The urinary electrolytes, creatin-
ine, urea and osmolarity were measured in the morning and
the total 24-h output was used to calculate the previous
day’s loss of Na+, K+, urea and the creatinine clearance.
Weight was carefully measured using weighing beds and
recorded on D2 and D7. The baseline weight was that re-
corded by the patient or a relative.
The daily intravenous fluid administration was based
on the monitoring of heart rate, arterial pressure, blood
lactate concentration, serial echocardiograms, cardiac
filling pressures and output and signs of fluid respon-
siveness in ventilated patients [26, 27].
Evaluation of extracellular volume
Sodium and fluid balances were calculated daily in
order to estimate changes in extracellular space. The
previous day’s inputs and outputs of sodium and
water were calculated each morning. All other losses
were measured, including from ileostomies and exter-
nal ventricular drainage when present. Sodium losses
were measured from all liquids and deducted from
sodium intake. The difference between water adminis-
tration from enteral nutrition and daily crystalloids or
colloid infusion and water loss was calculated. In-
sensitive losses were adjusted for body temperature.
The sodium and water gains or losses were calculated
daily and added to the previous day’s measurements
as cumulative fluid balance (ΔNa+ and ΔH2O). A
>36 g ΔNa+ or >4 L ΔH2O was defined as fluid over-
load [16–18]. The creatinine clearance was calculated
daily. All calculations were made by one caregiver
and verified by another (PEL, HF and BV).
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Blood volume measurements
The red blood cell volume (RBCV) was measured on D2
and D7 (±1 day), using 10 mL of the patient’s red blood
cells (RBC) labeled with radioactive chromium (51Cr-
RBC). We re-injected a known quantity of radioactive
RBC intravenously and collected two arterial samples 10
and 30 minutes later. From the radioactivity of these
samples we derived RBCV in mL/kg using the patient’s
body weight recorded before admission [28]. The arterial
hematocrit and RBCV defined the total blood volume
(TBV), in mL/kg and the plasma volume (PV), in mL/kg.
The normal values are 32 ± 6 mL/kg for RBCV, 72 ±
14 mL/kg for TBV, and 40 ± 8 mL/kg for PV. Hypovol-
emia was noted when TBV was <20 % of normal values
[28]. On D7, we also measured PV by intravenously inject-
ing a small amount of albumin labeled with radioactive
iodine (125I-albumin), and collected arterial samples at 10
and 30 minutes and at 2 h [29]. The normal PV measured
with 125I is 45 ± 10 mL/kg, slightly larger than that
measured with 51Cr-RBC [28].
Biomarker analysis
Plasma biomarkers were analyzed on D2, D5 and D7.
MR-proADM, Pro-ANP, renin, angiotensin II, aldoster-
one, cortisol, norepinephrine and epinephrine, copeptin,
pro-endothelin and EPO were measured for potential
interference with extracellular or blood volumes. All bio-
logic biomarkers were analyzed together after inclusion
in November 2014.
Statistical analysis
Because our original aim was to assess the correlation of the
biomarkers with intravascular volumes, the study sample
size was calculated considering that brain natriuretic peptide
(BNP) and EPO are good surrogate markers of intravascular
volumes. We then used published values of BNP and EPO
concentrations in similar patients [21, 30] to calculate the
number of patients needed (three groups of patients with
hypervolemia, normovolemia and hypovolemia, respectively,
considering the initial protocol with a 50 % between-group
difference and power of 80 %). Data were analyzed using R
[31]. The normality of data distribution was verified using
quantile-quantile plots and Shapiro’s test. Because most
data were measured with error, Deming regression with
equal variances was used to calculate the slope of the
regression curves.
Because biomarkers were approximately log-normally
distributed, comparisons between D2, D5 and D7 values
were performed on the log transformed data using the
Tukey test after analysis of variance (ANOVA). As our
objective was also the measurement of extracellular vol-
ume, we also studied fluid overload. For this purpose we
considered 4 L and 36 g as ΔH2O and ΔNa
+ (equivalent
to 4 L of saline), respectively, for the cutoff of response
variables [16–18].
We also calculated the performance of biomarkers to
predict a SOFA score >9. The calculation of ΔH2O and
ΔNa+ and SOFA score were performed on the same day
as the biomarkers were assessed. Because of the large
number of variables that were candidates for inclusion
in multivariate analysis, we first used random forest re-
gression [32] to select the most pertinent demographic
and biological covariates explaining fluid and sodium
overload and SOFA score. This was followed by linear
mixed effect regression in which subject and day of
measurement were considered as random effects due to
correlation between days of measurement.
Receiver operating characteristic (ROC) curves were
constructed to calculate the performance of the bio-
markers in predicting fluid and sodium overload (ΔH2O
and ΔNa+) and SOFA score. The optimal sensitivity/spe-
cificity cutoff for predictive variables was calculated,
using the non-weighted Youden index. The statistical
significance was set at P <0.05. Data are reported as
means ± standard deviation (SD), medians (25–75 per-
centiles) or counts and percentages or 95 % confidence
interval (95 % CI).
Results
In the first 7 days after admission to the ICU, 67 patients
including those with SBT (n = 21), SAH (n = 20), NCT
(n = 20) and PPS (n = 6) were studied. General demo-
graphic data, the number of patients studied in each
group and SOFA scores on D0, D2, D5 and D7 are shown
in Table 1.
Sodium and hydric balance
The cumulative sodium and water gains are reported as
ΔNa+ and ΔH2O on D2 and D7 in each study group
(Fig. 1). A fluid overload (i.e. more than 36 g of Na+ or
4 L of H2O) on D2 was observed in 43 patients (64 %)
for ΔNa+ and 36 for ΔH2O (54 %), and on D7 in 18
(27 %) for ΔNa+ and 33 (49 %) for ΔH2O. This sodium
and water positive balances on D2 and D7 were observed
in all groups, with a higher increase in sodium and water
in the NCT and PPS than in the SBT and SAH groups.
For example, on D2, a cumulative increase in Na
+ of 70
± 32 and 77 ± 28 g was measured in the NCT and PPS
group, in contrast to 43 ± 24 and 28 ± 24 g in the SBT
and SAH groups (P < 0.0001, Fig. 1a). The ΔNa+ was re-
lated to ΔH2O, confirming that retained water is related
to retained sodium (ΔNa+(g) = 7.2ΔH2O(L)-4.0; r
2 = 0.67;
P < 0.0001). As a known indicator of extracellular space,
plasma concentration of proteins and variation in weight
were related to ΔNa+ and ΔH2O, though these relationships
were weak (r2 = 0.44 and r2 = 0.35 for plasma proteins and
ΔNa+ or ΔH2O, r
2 = 0.27 and r2 = 0.33 for Δ weight and
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ΔNa+ or ΔH2O, P < 0.001 for all). Like plasma proteins,
hemoglobin was weakly related to ΔNa+ (r2 = 0.15) or ΔH20
(r2 = 0.23), P < 0.001.
Blood volumes
TBV, RBCV and PV were measured with 51Cr in 62 pa-
tients on D2 and in 63 patients on D7 (with
125I-albumin
in 58 patients on D7). TBV, RBCV and PV are shown in
Fig. 2. A decrease in TBV was observed in most patients.
Only 28 patients on D2 (45 %) and 31 on D7 (49 %) were
in the normal range. Hypovolemia (TBV <20 %) was
present in 34 patients (55 %) on D2 and 32 patients
(51 %) on D7. Low RBCV was observed in all but three
transfused patients (Fig. 2b). Decrease in RBCV was
sometimes notably low with a RBCV <50 % in 34 pa-
tients (55 %) on D2 and 21 patients (33 %) on D7. We
found no significant relationship between TBV or RBCV
and ΔNa+ or ΔH2O (see Additional file 1).
The distribution of PV was in the normal range
(Fig. 2c). Only 13 patients on D2 (21 %) and 10 patients
on D7 (16 %) were below the 20 % range. Importantly,
we found no relationship between PV and ΔNa+ or
ΔH2O (see Additional file 1). Identically, no correlation
was observed between PV and plasma proteins.
Hemoglobin concentration was weakly related to RBCV
(r2 = 0.33, P < 0.001) and was not related to PV (r2 =
0.026, P = 0.07). On D7, PV was measured by
125I-albu-
min in 58 patients. There was a statistically significant re-
lationship between PV calculated from 51Cr-RBC and PV
directly measured with 125I-albumin (P < 0.0001). The
slope of the Deming regression was 0.852 (0.610–1.08)
with an r2 value of 0.75.
Biomarkers
Detailed kinetics of all biomarkers are shown in Table 2.
Most biomarkers increased on D2 and decreased
significantly on D5 and D7 (copeptin, angiotensin II and
renin). MR-proADM and EPO decreased significantly on
D7. Cortisol, aldosterone, pro-ANP and pro-endothelin
remained unchanged. Plasma norepinephrine concentra-
tion was not reliable because it was infused as a
treatment.
Of all biomarkers tested, only MR-proADM and angioten-
sin II were significantly related to ΔNa+ (P = 0.01 and P =
0.03) and MR-proADM to ΔH2O (P < 10
-5). SOFA was re-
lated to ΔNa+ (P < 10-5), MR-proADM (P < 10-5), and EPO
(P= 0.03) (see Additional file 2). No difference was found as-
sociated to the type of pathological characteristics.
We constructed ROC curves with MR-proADM be-
cause it was the only predictor covariate common to the
three variables tested (ΔH2O, ΔNa
+ and SOFA). MR-
proADM has good discriminative properties with an area
under the curve (AUC) of 0.838 (0.780–0.888) for ΔH2O
and an AUC of 0.823 (0.764–0.880) for ΔNa+ (Fig. 3). We
determined a threshold of MR-proADM predicting a posi-
tive balance greater than 36 g Na+ or 4 L H2O. These
thresholds were 0.865 nmol/L (specificity 0.625 (0.538–
0.714), sensitivity 0.865 (0.787–0.933)) for ΔNa+ and
1.125 nmol/L (specificity 0.900 (0.833–0.9560, sensitivity
0.604 (0.513–0.694)) for ΔH2O. Furthermore, MR-
proADM predicted a SOFA score >9 with an AUC of 0.750
(0.658–0.830) and a threshold at 1.035 nmol/L (specificity
0.635 (0.560–0.711), sensitivity 0.762 (0.643–0.881)).
We also tested the relationships between biomarkers
and measured blood volumes. It is noteworthy that
among all biomarkers, only EPO was related to RBCV
(P < 10-5) but the ROC curve constructed for a 50 % de-
crease in RBCV revealed a low AUC (0.70 (0.60–0.78)).
Discussion
This study revealed that MR-proADM, a biomarker of
endothelial permeability [22, 23], may be used as a











Age, years 46 ± 19 38 ± 16 53 ± 14 39 ± 18 69 ± 16
Women/men 24/43 18/3 11/9 6/14 4/2
Weight, kg 75 ± 18 73 ± 14 53 ± 14 84 ± 22 71 ± 9
Height, cm 172 ± 10 178 ± 9 169 ± 9 173 ± 11 161 ± 8
IGS II 43 ± 13 49 ± 9 42 ± 12 37 ± 11 54 ± 10
Days in ICU 27 ± 22 34 ± 3 27 ± 16 22 ± 13 21 ± 6
SOFA scores
D0 10 (9–13) 10 (9–11) 9 (7–10) 12 (10–14) 15 (14–16)
D2 8 (6–11) 7 (6–11) 8 (4–9) 8 (8–11) 14 (12–14)
D5 5 (3–8) 5 (3–7) 4 (3-7) 5 (3-8) 7 (3–11)
D7 4 (2–7) 5 (2–8) 4 (3–6) 3 (1–6) 4 (1–7)
Values are means ± SD or median (interquartile 25–75 range). IGS II Index Gravity Score, SOFA Sequential Organ Failure Assessment
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surrogate for the increase in sodium and water balance
in the extracellular space, within the first week after ad-
mission of critically ill patients to the ICU. In addition,
we found no relationship between the increase in so-
dium or water balance and direct measurement of blood
volumes on D2 and D7. We found that MR-proADM
thresholds of 0.865 nmol/L for ΔNa+ and 1.125 nmol/L
for ΔH20 were predictive of fluid and of salt overloads,
respectively. Moreover, MR-proADM was related to the
concurrent SOFA score.
Excessive sodium and fluid balance is a risk factor for
morbidity and mortality in critically ill patients [7–9, 33]. A
reliable and easy to measure surrogate biomarker could be
very useful in improving the monitoring of fluid balance
and identification of patients with a positive interstitial fluid
and sodium balance. This biomarker should enable us to
better personalize therapy and to guide fluid resuscitation
and administration of vasopressors or diuretics.
While MR-proADM seems to be a particularly reliable
indicator of sodium and fluid balance, it does not
exclusively indicate capillary permeability. Indeed, MR-
proADM is a stable fragment of pro-adrenomedullin
which reflects levels of the rapidly degraded active pep-
tide adrenomedullin [22]. In addition to its role in vascu-
lar endothelial barrier permeability in blood vessels [23],
adrenomedullin also stabilizes the lymphatic endothelial
barrier [34] and is implicated as an important pleiotropic
effector of the host defense mechanism [35].
Fig. 1 a Cumulative sodium balance (ΔNa+, g) on day 2 (D2) and D7 in the 67 patients studied. b Cumulative fluid balance (ΔH2O, L) on D2 and D7.
Thresholds of 36 g for sodium and 4 L for water, corresponding to 4 L of saline and described as a tolerable fluid overload, are marked as shaded zone
around equilibrate balances. SBT severe brain trauma, SAH aneurysmal subarachnoid hemorrhage, NCT severe non-cerebral trauma, PPS postoperative
peritonitis with shock
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Fig. 2 Total blood volume (TBV, mL/Kg) (a), red blood cell volume (RBCV, mL/Kg) (b) and plasmatic volume (PV, mL/Kg) (c) on day 2 (D2) and D7.
Thresholds of 20 % around normal values are marked as shaded zones. SBT severe brain trauma, SAH aneurysmal subarachnoid hemorrhage, NCT
severe non-cerebral trauma, PPS postoperative peritonitis with shock
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In the ICU, fluid balance is evaluated by the use of in-
put/output charts and by the daily measure of weight.
However, it is time consuming and difficult to perform
accurately. In addition, the present study identified a
weak relationship between weight and fluid balance.
Measurement of patient’s weight in inflammatory disor-
ders may be biased by practical issues but also by loss of
muscle mass, interfering with the estimate of fluid over-
load. Moreover, we found that the usual markers of
extracellular volume, such as plasma proteins and
hemoglobin also had a weak relationship with sodium or
water balance. Thus, the monitoring of sodium and fluid
balance is currently a difficult task using tools that have
their own limits. MR-proADM concentration, on the
other hand, offers a measure of sodium balance and
extracellular space, which could be used as a good surro-
gate to improve fluid balance monitoring. Possibly, it will
be useful in the future to test a score centered on MR-
proADM but also taking into account simple values such
as basal weight or plasma proteins, to easily obtain an
even better measurement.
No marker accurately estimated the TBV, PV or RBCV.
Moreover, ΔNa+ or ΔH2O are not predictors of blood vol-
ume. We found no relationship between fluid balance and
Table 2 Evolution of all biomarkers
Biomarkers Normal values
(min-max)
Day 2 Day 5 Day 7
Number M (25–75) Number M (25–75) Number M (25–75)
Angiotensin II (pmol/L) 19–38 58 21 (8–38) 65 9 (6–18)* 67 9 (5–12)**
Renin (pg/mL) 3–16 67 52 (14–93) 65 15 (6–64)* 67 14 (6–36)**
Aldosterone (pg/mL) 42–201 67 33 (14–111) 65 47 (19–105) 67 54 (16–127)
Pro-ANP (pmol/L) <85 67 54 (31–110) 65 68 (48–105) 67 59 (34–97)
Pro-endothelin (pmol/L) 34–55 67 62 (47–83) 65 59 (50–70) 67 53 (43–73)
CT-proAVP (pmol/L) 1.1–16.4 67 19 (11–43) 65 13 (6–22)* 67 11 (5–21)*
MR-proADM (nmol/L) <0.39 67 1.05 (0.79–1.85) 65 1.05 (0.75–1.46) 67 0.76 (0.6–1.15)*¥
Cortisol (ng/dL) 9–22 67 19 (14–27) 64 22 (18–27) 67 23 (19–28)
Epinephrin (pg/mL) <80 66 89 (50–152) 65 95 (60–184) 67 113(55–180)
Norepinephrine (pg/mL)a <450 67 1773 (630–4100) 65 762 (448–1473) 67 705 (437–1326)
EPO (mUI/mL) 6.4–63.8 66 52 (27–90) 65 38 (22–65) 67 28 (17–38)**¥
Min-max are the lowest and highest normal values. M (25–75) is median (interquartile 25–75 range). aNo statistical analysis was performed because
norepinephrine was used as a treatment in a significant number of patients (n = 30 at day 2 (D2), n = 12 at D5 and n = 10 at D7). ANP atrial natriuretic peptide,
MR-proADM mid-regional pro-adrenomedullin, EPO erythropoietin. *P < 0.01 vs D2; **P < 0.001 vs D2;
¥P < 0.05 vs D5
Fig. 3 ROC curves to describe the relationship between the plasmatic concentration of mid-regional pro-adrenomedullin (MR-proADM) and fluid overload of
4 L for ΔH2O and 36 g for ΔNa
+. Area under the curve (AUC) is 0.838 (0.780–0.888) for ΔH2O and 0.823 (0.764–0.880) for ΔNa
+ determining the relationship
between dangerous fluid overload and plasmatic MR-proADM. The Youden index indicates a threshold for plasmatic MR-proADM (0.865 nmol/L (specificity
0.625/sensitivity 0.865) for ΔNa+ >36 g and 1.125 nmol/L (specificity 0.900/sensitivity 0.604) for ΔH2O >4 L) to predict fluid overload
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plasma volume. This was particularly unexpected, because
plasma volume expansion is the main justification for fluid
infusion. Yet, plasma was the only volume that was in the
normal range on D2 and D7. The absence of correlation
between PV and fluid balance supports the hypothesis of
possible trapping of Na+ and water in the interstitial vol-
ume [36, 37]. Tighter control of PV would be useful in
daily practice, though we did not find relationships with
biomarkers, proteins or hemoglobin. This issue warrants
further examination with a combination of other bio-
markers or predictors.
The good correlation between the measurements of
PV deducted from RBCV with 51Cr and directly mea-
sured with 125I-albumin at D7 strengthened our results.
The distribution volume of albumin may be larger than
that obtained with RBC, especially when the capillary
permeability is pathologically increased. On D7 the dif-
ference was weak, suggesting that the capillary perme-
ability was nearly repaired. While it would have been
worthwhile to examine this comparison on D2, this was
precluded by the interactions between 125I and some of
the measurements of biomarkers.
The observation of a decreased RBCV is common and
explains low TBV. The measurement of RBCV with 51Cr
is a recognized method but requires time [28]. As
hematocrit, hemoglobin is dependant of the ratio be-
tween RBCV and PV, we found, as others, that
hemoglobin concentration is a poor surrogate for RBCV
in ICU [38]. EPO is related to RBCV but the ROC curve
is not sufficiently discriminative. We found no good bio-
marker of RBCV to help address this problem.
The present study has some limitations. First, we
found no marker that describes blood volume. We need
a better understanding of all physiologic determinants,
including capillary permeability, hormonal influences
and low RBCV and interactions among theses determi-
nants. On the other hand, we identified a biomarker of
cumulative salt and water balance, which could be an in-
teresting tool for fluid management in the ICU. Second,
we made our study measurements on D2, D5 and D7,
long after the admission of patients into the ICU, often
after the peak of the disease manifestation. The
distribution of extracellular volume may be different at
D0 during initial resuscitation. The precise timing of
measurements may also be a critical factor. While our
study observed the changes that took place on D2 and
D7 after an acute event, further studies are needed to fill
the gaps.
Our study was observational. Patients who were in-
cluded reflect the daily practice of our service. However,
the group of patients as a covariate did not influence the
prediction of fluid balance or blood volume, suggesting
that volume abnormalities are independent of the path-
ology. Other studies will need to confirm our results.
Conclusion
A positive sodium balance is an important negative
prognostic factor. We found that MR-proADM is a valu-
able surrogate to evaluate sodium and fluid overload in
the first week after an acute and critical inflammatory
illness. MR-proADM could improve the fluid balance
monitoring and guide fluid resuscitation and administra-
tion of vasopressors or diuretics. After this first step,
further studies are needed to test the ability of MR-
proADM monitoring to control or prevent fluid over-
load and organ failure.
Additional files
Additional file 1: Lack of relationship between cumulative sodium
balance (ΔNa+, g) (A); cumulative fluid balance (ΔH2O, L) and total blood
volume (TBV, mL/Kg), red blood cell volume (RBCV, mL/Kg) and plasmatic
volume (PV, mL/Kg) at D2 and D7 (B). (DOCX 47 kb)
Additional file 2: Random forests perform regression using decision trees. It
is a non parametric machine learning method using a series of random
decisions at each tree. We used random forests to perform an initial choice
between the large number of variables to enter in the second phase of
regression. A SOFA (top), ΔH2O (middle) and ΔNa
+ (bottom) variable importance
measured by random forests. This figure displays the dot chart used to choose
the variables entered into the linear mixed-effect regression model. On the left
is the normalized mean square error (MSE), on the right, the node impurity is
the residual sum of squares. B Results of the mixed effect modeling for ΔNa+,
ΔH2O and SOFA using the lme procedure from R. (DOCX 322 kb)
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